Joyce O'Shaughnessy, MD ACT TC Jan 2026
Автор: Agendia Inc
Загружено: 2026-02-20
Просмотров: 8
Описание: During this interview, Dr. Joyce O'Shaughnessy discusses the latest ACT-TC data from the FLEX Study presented at SABCS 2025. The data show that MammaPrint + BluePrint can predict which HR+/HER2- early stage breast cancer patients may benefit from the addition of adjuvant anthracycline. This data is also now recognized in the latest 01.2026 NCCN Guidelines.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: